Mortality in Pulmonary Arterial Hypertension Patients Treated with Continuous Prostanoids.

Sonja D Bartolome,Namita Sood,Trushil G Shah,Kim Styrvoky,Fernando Torres,Kelly M Chin

Chest（2018）

引用 13|浏览4

暂无评分

摘要

In PAH patients receiving treatment with a parenteral prostanoid, survival associates significantly with the number of guideline recommended lower-risk and higher-risk criteria achieved at first follow-up.

查看译文

关键词

biomarkers,catheterizations,pulmonary arterial hypertension

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要